1193
www.klinickafarmakologie.cz340804301076513320121425327329234035839843647950254457164568672477179183988990895196610061045
/26228043010757
KlinFarmakol2698804301077091109157209246273347388426473493
Farm2020;3201804301074279105180234277318361377
34(3):3589804301074488113155176191
135–1413790804301074481123169208247285
/40948043010757
KLINICKÁ41718043010771114135194215268315373
FARMAKOLOGIE4556804301074191138210265312372415474533554598
A51668043010753
FARMACIE5231804301074291138211266317337380
14156558026012657110163
PŘEHLEDOVÉ4549207012660124182256312369444520587645
ČLÁNKY5216207012660115187259327395
Současný222436501063171112147189223263301
pohled254036501063374115146179218
na277436501063979
podávání286936501063374114152187223265282
intravenózních31663650106165789125167202234275316347389406440481
imunoglobulinů366236501061670111152193233264303339380411429470511
u4189365010639
pacientů424336501063370103121152194226267
s4525365010632
toxickou457236501063069104122156192231272
epidermální48593650106306683122154190245285316358375
nekrolýzou525036501063971107143183215248282321362
venous3405540833266104142180206
immunoglobulin.5625540831270127165203241281296334373412427442480493
Science1068554083326479114152184218
1998;1299554083346499134146
282(5388):14585540833568102119152185220255273285
490–493.17565540833467103141178211243256
38.340653085367288
Firoz443654083355071108136
BF,597654083356874
Henning6886540834580118156171209248
JS,951654083265871
Zarzabal1039654083387192123156196229244
LA,1298654083347791
Pollock1406654083367288103141174204
BH.1628654083358093
Toxic1737654083346899114146
epi‑1898654083367691113
dermal340754083387394153185200
necrolysis:5547540833873105126164180211238253279292
five860754083163366100
years974754083316597118145
of11337540833756
treatment1205754083204175107129187222260282
experience15007540833466105141162178212250283316
from1832754083163876134
a198075408331
burn340854083397798137
unit.492854083377590113126
J63385408324
Am6738540834199
Acad7878540834172105144
Dermatol9478540834580102160192214251267
2012;12298540833569100130143
67(4):1387854083346783116134146
630–635.15488540833468102140178211244256
39.340953085367082
Stella436954083365688102116147
M,6009540835567
Cassano684954083407196122153190227
P,9289540833538
Bollero984954083357287100134154189
D,11919540834555
Clemente1263954083405487143177214234266
A,15479540834153
Giorio1618954083435794114128165
G.18009540834456
Toxic1870954083366998112142
epidermalnecrolysistreatedwith3401054083347184121154173229259273319352383402437451481506519543574593625655675706744803817837873
intravenoushigh-dose1227105408310466685116145178214250286310356370406442462501537561594
immu‑183510540831065121156177
noglobulins:34011540833874113126163201238252266302327338
our6911154083377493
experience.79711540833464102136156170204240271303314
Dermatology11241154083457999156187207243257294332363
2001;149911540833467102132139
203(1):16511154083346698115145158169
45–49.183211540833466101136168177
40.3401253085367489
Tristani-Firouzi444125408335526894117150188203225259274296333371400416
P,87512540833842
Petersen9331254083377193127148175210248
MJ,11991254083548092
Saffle13071254083346786104121156
JR,14791254083266276
Morris157312540835493114136152178
SE,17661254083356780
Zone186412540833875113148
JJ.3401354083244861
Treatment4141354083335084116138196231269291
of71813540833857
toxic7901354083205788103135
epidermal9391354083347389128163184242275290
necrolysis124313540833772105126164179211238253279
with15361354083516689127
intravenous1678135408313517394127159193231269307334
immunoglobulin34014540831575135174213253294310350391430447462502
in85814540832060
children.9341454083377793109149171207246260
J1210145408331
Am1257145408347107
Acad138114540834780114155
Dermatol155714540834783106166200223261278
2002;185114540834076113148161
47(4):3401554083346683116133145
548–552.50015540833470105142176209242254
41.3401653085366981
Bachot43616540833568101139177199
N,65016540834558
Revuz72316540833570103141170
J,90916540832436
Roujeau96016540833574112127162194231
JC.12071654083246578
Intravenous1300165408315537596129161195233271309336
immunoglo‑165116540831572130168206244284299337360
bulin3401754083397894109148
treatment5031754083285084117139198234272294
for8131754083246284
Stevens-Johnson9131754083386094127162201228249271310349388415454493
syndrome142217540833164104144165203262298
and173617540833776116
toxic18671754083286596112145
epidermal3401854083347389128162184242274290
necrolysis:64818540833873105126164180211238253279292
a955185408335
prospective10081854083396097124163199231255271303337
noncomparative136418540833775114146183241280313335368389405437471
study18511854083295290129161
showing34019540832664102153169207246
no60419540833876
benefit69819540833975113148165182205
on92119540833776
mortality101519540835796117142175190205228261
or129519540833759
progression.13721954083396097137158192219246260298337350
Arch17401954083416394132
Der‑189019540834581102122
matol34020540835790111148164
2003;52020540833468104137149
139(1):6842054083346497116148162174
33–36.87420540833467103135170183
42.3402153085377390
Campione44621540834681141182198238278314
E,77621540833953
Marulli85121540835690112152169185200
GC,107321540834587101
Carrozzo119121540834680103126164194227265
AM,1473215408347105119
Chimenti160821540834787103162199239261278
MS,190721540835691104
Costanzo34022540834077104127160198227264
A,62222540834155
Bianchi6922254083385486124156194209
L.91622540833448
High-dose9822254083445998136158199237263298
intravenous1296225408317557698131162197235273311337
immunoglo‑164922540831775132170208246286301339363
bulin3402354083397792107145
for5002354083236182
severe5982354083306598132153187
drug80123540834263101141
reactions:9572354083255991123147163200239265278
efficacy1250235408339577593125158190223
in148923540831957
toxic15612354083266393109141
epidermal17172354083387893132167188247279294
necrolysis.34024540833873105126164180211238253279293
Acta6482454083417397130
DermVenereol79324540834581102160195227265300322356394410
2003;121924540833468104137149
83(6):13832454083346886119137149
430–432.154824540833466101139176208241253
43.3402553085367186
Trent4402554083335084122143
JT,5992554083235766
Kirsner6792554083355172100137172194
RS,8872554083356982
Romanelli98325540833573131164202237252268282
P,128025540833539
Kerdel13332554083356991129164179
FA.15262554083337185
Analysis162525540834179112127159186201227
of186625540833756
in‑19382554083135173
travenous3402654083214275105139176214251277
immunoglobulin63226540831268125162199237276291328367404419434471
for11182654083155273
the12062654083195690
treatment13112654083194073105126183217255276
of159926540833755
toxic16692654083195585100131
epider‑18132654083337287125159180199
mal34027540835790105
necrolysis46027540833772105126163179211238253279
using7532754083376479117156
Scorten:92327540833265102123148182220232
The116927540833372107
University12912754083438196129163184211226249282
of158827540833756
Miami165927540835470102160175
Expe‑184827540833365105140164
rience.3402854083213671109141175187
Arch5422854083416394132
Dermatol68928540834581102160193214251267
2003;97228540833468104137149
139(1):11362854083346497116148163174
39–43.132628540833467105142174187
44.3402953085367489
Prins4422954083355571108134
C,58929540834052
Kerdel6542954083356989127162177
FA,8442954083326983
Padilla94029540833567105120135150182
RS,11342954083366982
Hunziker122829540834481119148163193227248
T,148929540833241
Chimenti15422954083407792149184222243258
S,181329540833245
Viard18702954083365284104142
I,34030540831527
Mauri38030540835486124145160
DN,55330540834590103
Flynn6683054083324778117155
K,83530540833549
Trent8973054083335083121142
J,105530540832133
Margolis110130540835486107145183198213239
DJ,13533054083456779
Saurat144430540833365103124156178
JH,16373054083226679
French17283054083335286124156193
LE.19343054083316477
Treatment3403154083324982113134191226263284
of63631540833756
toxic7063154083195585100131
epidermal8493154083347287125159180237269284
necrolysis114531540833771103124160176207233247273
with14303154083506587124
high-dose15663154083375290127149188226252286
intra‑1867315408312497091123145
venous34032540833165102140178203
immunoglobulins:55832540831269126163201238277292330369406421436473499511
multicenter108232540835693108130145176210247268301322
retrospective1419325408318517394131157196230263286301333367
analysis179832540833269101116147174188214
of34033540833757
4841233540833470
consecutive49733540833268107133168201239261277309343
cases.8563354083316490125152166
Arch10373354083416293131
Dermatol118433540834580102160192214251267
2003;146633540833569105138149
139(1):16313354083346497116148162174
26–32.182033540833568106138171183
45.3403453085367083
Al-Mutairi4383454083415576131167188220233253267
N,72034540834556
Arun7913454083416198134
J,93934540832536
Osama98934540834773105161192
NE,11963454083447688
Amr129934540834197117
Z,143134540833749
Mazen149534540835485114146183
AS,16933454083417385
Ibtesam17923454083155374106131163219
el-A,3403554083354971111125
Nazeha48335540834577106140177209
el-B.7063554083395475112124
Prospective,8443554083406097123161196228251266298331342
noncomparative120535540833876114145182240278311331363384399431464
open168835540833877112149
study18523554083305390129160
from3403654083183975132
Kuwait48536540833570120152166187
of68536540833755
the7543654083205791
role8593654083195570103
of97536540833755
intravenous1044365408314517191122152185222259296320
immunoglobulin137836540831470127163200237275289325364400414428464
in185636540831451
the19203654083215892
treatment3403754083224275106126183217254275
of63337540833755
toxic7023754083266191105136
epidermal8523754083387690128162182239270285
necrolysis.115437540833872104124160175205231245270282
Int14503754083195576
J1540375408328
Dermatol158637540834580100157188209245259
2004;185937540833972107142152
43(11):3403854083346582112139152162
847–851.5153854083346999130165198227235
46.3403953085367489
Brown4453954083386097148187
KM,64739540833794107
Silver770395408335506597131153
GM,94139540834398112
Halerz10713954083447691126147178
M,126739540835468
Walaszek135339540835788104136163192226257
P,162539540833842
Sandroni168239540833668106146167204242257
A,195739540834155
Gamelli34040540834476134169184199214
RL.5674054083366882
Toxic6624054083326696112143
epidermal8184054083347389128162184242274290
necrolysis:112040540833873105127164180211238253279291
does142440540833877112139
immunoglobu‑157840540831270128165203241281296334373412434
lin3404154083153068
make42141540835789120154
a588415408332
difference?633415408338537392126147181219252285310
J958415408322
Burn9934154083367495133
Care11404154083397293128
Rehabil128141540833570108140180195210
2004;150541540833468104140152
25(1):16704154083346987119133145
81–88.18284154083346699135170184
47.3404253085367079
Shortt43442540833674112133158182
R,63242540833852
Gomez70242540834483141176206
M,92642540835468
Mittman10124254083547092117175207245
N,127542540834558
Cartotto13514254083407394119156178202239
R.160542540833953
Intravenous1673425408318567899132164198236274312339
immunoglobulin34043540831573131169207246286301340380418434449487
does84343540834382117144
not100343540834381104
improve112243540832078117139177209244
outcome138143540834381104135172231266
in166343540832058
toxic17364354083276495111143
epi‑18944354083407995118
dermal3404454083387394153185200
necrolysis.55644540833772105126163179211238253279293
J864445408324
Burn9034454083367495133
Care10524454083407394128
Rehabil119544540833570109141180196211
2004;142144540833469105141153
25(3):15894454083346987120138149
246–255.175444540833466102140171206239251
48.3404553085367287
Kim44045540833550106
KJ,5594554083356272
Lee6444554083326498
DP,7554554083468083
Suh85145540833369105
HS,9694554083447587
Lee10684554083326599
MW,1179455408355111119
Choi131145540834076113127
JH,14524554083236778
Moon154345540835592129166
KC,17224554083357284
Koh181945540833571108
JK.19414554083235771
Toxic3404654083326594107138
epidermal4884654083347185122156175232263277
necrolysis:77546540833770102121157171201227240265276
analysis10614654083316898112142168181206
of127746540833754
clinical1341465408332455995108139170184
course153546540833166103122148181
and172646540833268106
SCOR‑184246540833271115150170
TEN-basedcomparisonofmortalityrateandtreatmentmodali‑340475408332651081291671982232562943343694264634945145285525886256726897567938128358668808939149469761007102710591101113711741205122512571287130713641397143314531520155615941624163816511672
ties340485408321356892
inKoreanpatients.ActaDermVenereol2005;85(6):497–502.4464854083114690126146178208244291322342356388424444470482532561583614669702721777822853889922941973101010241068110011341166117512181250126612971314132413671398142914601492152415551565
49.3404953085357083
Lissia436495408331467197112143
M,59149540835467
Figus6704954083324785122147
A,83049540834054
Rubino89649540833572110125162200
C.110849540834052
Intravenous1175495408312507191124155188225263300326
immunoglobulins151649540831268125162199237276291328367404419433471496
and34050540833169107
plasmapheresis4595054083385485111168199238275310330364390404430
combined90150540833167124163178215249288
treatment12045054083183973104125182216254275
in149350540831249
patients15555054083387091106140177198225
with17935054083506587124
se‑19295054083266083
vere3405154083326687121
toxic4775154083195686102134
epidermal6245154083347388127162183242274289
necrolysis:92651540833873106127164180212239254280292
preliminary12315154083396195110125183198236268289323
report.15705154083185291130152176190
Br177351540833556
J1845515408322
Plast18805154083355082108131
Surg3405254083327091129
2005;48452540833569105139150
58(4):6495254083346887120138150
504–510.81452540833468104142176207238251
50.2139553085367287
Mangla22465540835487125164179212
K,24735540833954
Rastogi2542554083397299122159198213
S,27715540833649
Goyal28405540834382113146162
P,30175540833944
Solanki3076554083377591123161191208
RB,3299554083407689
Rawal34035540834072123156171
RC.3590554083398093
Effi‑369955408336547290112
cacy2139654083316496130
of22856540833757
low23576540831654105
dose24786540833977103138
intravenous263265408315537596129161195233271310336
immunoglobulins29836540831674131169207245285300338378416431446484511
in35096540831654
children3578654083327085100139160195233
with2139754083516689127
toxic2281754083256292108139
epidermal2436754083377692130165187245277293
necrolysis:27477540833873105127164180212239253280292
an30547540833573
open31467540833776112150
uncontrolled33147540833876108145183205226263279294329369
stu‑3698754083295290113
dy.2139854083387080
Indian2234854083155392107139177
J242785408324
Dermatol24668540834581102160193215252267
Venereol27498540833568106141162197235251
Leprol30158540833266105127164180
2005;32108540833469105139150
71(6):3375854083346782115133145
398–400.35358540833468103139176212248261
51.2139953085367082
Tan22369540833765103
AW,23589540834197106
Thong24809540833675114152191
BY,2686954083407483
Yip2784954083395594
LW,28939540833691100
Chng30139540834077115154
HH,31879540834489101
Ng33089540834483
SK.3407954083367186
High-dose3512954083445998136158199237264299
intravenous2139105408315537495128160194232271309335
immunoglobulins248910540831371128166204242282297335375413429443481508
in301210540831350
the30781054083195792
treatment31861054083194175107128187222260281
of348110540833756
toxic35521054083205787103135
epi‑37001054083347389111
dermal21391154083387293150182197
necrolysis:234811540833772104125161177208234249274286
an264711540833168
Asian27281154083406882113151
series.2891115408326608196130157170
J3076115408321
Dermatol310911540834580101158190211247263
2005;338411540833467103137147
32(1):35431154083346683114128139
1–6.369511540833466102115
52.21391253085367084
Yeung223512540833565102138176
CK,24231254083397387
Lam252112540833164120
LK,26521254083316679
Chan274312540833976107144
HH.289812540834488100
The300912540833371105
timing31281254083183389103140178
of331712540833755
intravenous3387125408311486889121151184221258295321
im‑37221254083116889
munoglobulin213913540835692128164202216252290326340353389
therapy25391354083215791110141179208
in276113540831147
Stevens-Johnson28181354083325284114147183207227247283320356380417453
syndrome32821354083255693130150185241274
and356713540833167104
toxic3682135408321568498129
epidermal21391454083347287125159180238269284
necrolysis.243414540833872104124161176207233248273286
Clin27311454083405569106
Exp284914540833264103
Dermatol296314540834680101158190211247262
2005;323714540833467103136146
30(5):33951454083346786119137148
600–602.355414540833569105142178213245257
53.21391553085367186
Yip22421554083355190
LW,23481554083338897
Thong246115540833473111150189
BY,26661554083367079
Tan276015540833462100
AW,287715540834196106
Khin30001554083357489127
LW,31421554083338898
Chng325715540833977115154
HH,342815540834489102
Heng354715540834479117156
WJ.37201554083577891
High-dose21391654083446099138160201240267303
intravenous24571654083205980102136168202241280318345
immunoglobulin281816540832078136174213252292307346386425440456494
in332816540832058
the340116540832866102
treatment35181654083274984116138197232271293
of213917540833757
toxic22111754083215888103135
epidermal23611754083347389127162184242274290
necrolysis:266517540833873105127164180212239253280292
a2972175408331
study30191754083254886125157
of319117540833756
ocular326217540833770107123155176
benefits.345217540833975113148165182205232246
Eye37121754083336498
(Lond)21391854083195088126165185
2005;233918540833468104138149
19(8):25031854083356584118136148
846–853.266618540833470107144181215248260
54.21391953085367389
Imahara224319540832078111149182203236
SD,24941954083388394
Holmes26091954083448399156192219
JH284319540832974
4th,29331954083396199112
Heimbach30661954083447994152192225257295
DM,3382195408345101114
Engrav351219540833775115136169201
LE,37281954083377083
Honari213920540834482121153174190
S,234320540833245
Klein24022054083355286102139
MB,255520540835591104
Gibran26732054083435998119152190
NS.28772054083457791
SCORTEN298220540833273118154188222267
overestimates326320540833769104125159186209224282314336370397
mor‑367420540835795117137
tality2139215408322547085107141
in229521540831856
the23662154083246398
setting24792154083296486111126164203
of270021540833757
a2772215408335
standardized28222154083295285123162194215253269298332371
treatment32092154083244680111133191226265286
protocol.35132154083396098120157189226242255
J3783215408327
Burn21392254083357394133
Care22872254083407394128
Res24312254083357097
2006;254322540833468105140153
27(3):27112254083346783117134146
270–275.287222540833567101139170203236248
55.21392353085367185
Paquet223823540833567106144178201
P,245223540833540
Kaveri250523540833468100134155171
S,268923540833245
Jacob27492354083225487124163
E,292523540833346
Pirson2984235408335507198136175
J,317423540832234
Quatresooz322123540834785118139161195222260299327
P,356123540833540
Piérard36142354083354984105138159198
GE.21392454083447790
Skin22432454083336379117
immunoglobulin237524540831472129167205243283298336376414429444482
deposition287224540833873112151177192215230268306
following3194245408317557086124175190228267
intravenous3476245408314527395128159194232270308334
immunoglobulin213925540831572130168206244284299337377415430445483
therapy26372554083226095117150189220
in287225540831553
toxic29402554083225989105137
epidermal30922554083347389128163184242275290
necrolysis.339825540833772105126163179211238253279293
Exp370625540833365105
Dermatol213926540834581102160193214251267
2006;242226540833468104140152
15(5):25892654083356582116134146
381–386.275026540833569101134166200236249
56.21392753085367288
Gravante22402754083446598130163201222256
G,250927540834357
Delogu25792754083458196134174211
D,280327540834656
Marianetti287227540835587109124156194229251276291
M,317627540835468
Trombetta32572754083324987145184220242266299
M,356927540835468
Espo‑36502754083326099138161
sito21392854083264164101
G,226128540834458
Montone233928540835594133155192231266
A.262128540834661
Toxic269828540833872103118151
epidermal28642854083407995134170191250283298
necrolysis317828540834378111133170187219246261287
and348128540833776115
Steven36122854083375993126160199
Johnson213929540832462101139165204242
syndrome:239629540833063102141162199257293305
11-years27162954083386685117151183204231
experience296329540833869109144165181216254286320
and329829540833674113
outcome.342629540834179102133170228263275
Eur37162954083377495
Rev213930540833570103
Med225730540835489129
Pharmacol240130540833573105126185217249286302
Sci27183054083336580
2007;281430540833468104137146
11(2):29763054083346277111128140
119–127.31323054083346292129160190223229
57.21393153085367180
Stella22323154083325387102117149
M,239431540835468
Clemente24743154083405590147182220241275
A,276231540834154
Bollero28293154083367489104139160197
D,303931540834556
Risso31083154083355076103141
D,326131540834556
Dalmasso33303154083457792150182208235273
P.361531540833540
Toxic36683154083336797112144
epidermal21393254083347389128162184242274290
necrolysis244432540833772105126163179211238253279
(TEN)27383254083195489133152
and290532540833270109
Stevens-Johnson30293254083325487120154192218239261299337375402440478
syndrome35233254083255897136157194253288
(SJS):21393354083195075107126138
experience229233540833971110146167183218256288322
with26343354083516689127
high-dose27763354083435897135157198236263298
intravenous30893354083205879101134165200238276314340
immunoglo‑344533540831977135173211249289304342366
bulins21393454083397793108146173
and232734540833775115
topical245734540832764104120152185201
conservative267334540833774112139174196231264286301334368
approach.305734540833776116138175209241279293
A3365345408346
retrospective34273454083266083104142169208244277301316349384
analysis.213935540833270102117149176191217231
Burns23853554083357395133159
2007;256035540833468104137147
33(4):27223554083346785118135147
452–459.288535540833467100134171204236247
58.21393653085356983
CartottoR,MayichM,NickersonD,GomezM.SCORTENaccu‑2232365408339708911114616518722226627834037139941344247854155260561864867670772675178782387788693897410301062108911521164120512431286132013511383142514661496152415591579
ratelypredictsmortalityamongtoxicepidermalnecrolysispati‑21393754083205272104118148196215248285299329351377444481500523554568581602634675731768804841873908936950980102410611075111211451164122112511265131213451376139614311445147515011514153815861617163716511672
entstreated21393854083336989114145165196226246277315
inaburncenter.JBurnCareRes2008;29(1):141–146.2467385408311468713417019022626629833335338440441244549052554458163066067971175578881385688892295596510081040105810871100111011531182121012411269129813321343
59.21393953085367184
Dorafshar224239540834584106139157185223255276
AH,25373954083418598
Dickie26533954083466193123140174
SR,28433954083357084
Cohn294639540833976115153
AB,31173954083417790
Aycock322539540834171102139172202
JK,34423954083286378
O’Connor353839540834760100137176214252273
A,213940540834155
Tung220840540833266104143
A,236540540834055
Gottlieb243340540834483105129144159194233
LJ.26804054083315971
Antishear276540540834179100116142180215247268
therapy30484054083205893114147187218
for32814054083175576
toxic33734054083205687102134
epidermal35214054083347389128162184242274290
necrolysis:213941540833873105126164180211238253279292
an244641540833573
alternative25344154083355072106127166198220235268302
treatment28524154083244579111133191226264286
approach.315341540833574114135172205238276289
Plast34574154083385385111135
Recon‑360741540833873106143181204
str21394254083264971
Surg22254254083337091129
2008;236942540833569105140152
122(1):25374254083346499116148162174
154–160.272642540833465100137168199234247
60.21394353085367388
Schneck224043540833264102140174207237
J,249243540832133
Fagot253843540833261100138159
JP,27134354083215761
Sekula27874354083326797135150182
P,298143540833540
Sassolas30334354083336592118156172204230
B,327543540833648
Roujeau333643540833573111126160192229
JC,35804354083226375
Moc‑366843540835492125143
kenhaupt213944540833064102140172210249271
M.243044540835468
Effects25134454083375675110142166194
of272244540834261
treatments27994454083254781113135193228266287315
on312944540834280
the32254454083266499
mortality334344540835896118142175190205228262
of362044540834161
Ste‑36964454083375892115
vens-Johnson213945540833266104131152173211250288314353391
syndrome254545540833264103142163201259294
and285545540833674114
toxic29844554083276494110142
epidermal31414554083397894133168189247280295
necrolysis:345245540834277110131169185216243258284297
A3769455408341
retrospective2139465408321557798136162201237270294309342376
study25304654083315492131163
on270846540834281
patients28044654083437698113148186208235
included30554654083195789104142181216255
in332646540831957
the339846540832665100
prospecti‑351346540834365102129168203236260275298
ve213947540833266
EuroSCAR22204754083326990127159200242278
Study.25134754083335492131163173
J2701475408324
Am274047540834098
Acad285347540834173106145
Dermatol301247540834681102161193215252268
2008;329547540833468104139152
58(1):34614754083356988119134146
33–40.362247540833467103140176188
61.21394853085366981
Rajaratnam22384854083356883116137170191230262320
R,257548540833549
Mann264248540835487125163
C,282248540834053
Balasubramaniam28924854083356884116142180219240273331363401416448506
P,341548540833640
Marsden347248540835587109136175210248
JR,37354854083266276
Taibjee21394954083326074113128162197
SM,23484954083328699
Shah245949540833269101139
F,261049540833238
Lim266049540833146103
R,277549540833549
Papini283649540833566104120157171
R,302049540833548
Moiemen308149540835391106140197232269
N,336249540834557
Lewis343149540833165115131156
H.359949540834457
Toxic36684954083336696111142
epidermal21395054083347389128162184242274290
necrolysis:244450540834176109130168184215242257283296
retrospective27555054083245881102139166205241273297313345380
analysis315050540833573106121153180195221
of338650540834160
21346250540833769
consecu‑354650540833572111137172205242265
tive21395154083223769104
cases22585154083366995130157
managed243551540835890128160199234274
at272451540833758
a2798515408336
tertiary28505154083266081106121153174208
centre.307351540833670108130151185197
Clin32865154083446075112
Exp341451540833770109
Dermatol354351540834681102161193215252268
2010;213952540833468100131144
35(8):22995254083346784118136148
853–862.246252540833569102138174209243255
62.3938553085367187
Atzori4044554083416293130152167
L,42275540833448
Pinna4290554083385390128161
AL,4469554083417386
Mantovani45745540835487125146183215248286301
L,48905540833548
Ferreli4954554083356990112146162177
C,51495540834053
Pau52175540833870108
M,53435540835468
Mular‑54295540835592108140161181
gia3938654083385385
M,40406540835468
Aste4124654083416992126
N.42676540834458
Cutaneous4341654083407799132170205244282308
adverse46646540833473105140161188223
drug4904654083385997136
reactions5055654083225688120145160198236263
to53336540832360
allopu‑5408654083334964102141180202
rinol:3938754083213674112128140
1040947540833870
year41797540833569101122
observational43177540834181108143164199231253269306345377393
survey4725754083306889123158189
of49307540834160
the5006754083266499
dermatology5120754083427799157189211248264302342374
de‑55097540834277101
partment–Cagliari3938854083407496121181217257279314358392433449464497519536
University44958540834584100133169191219235258293
(Italy).480485408325406397113146165177
J499785408330
Eur5043854083397799
Acad51588540834780114154
Dermatol53348540834682105165198221259276
Venereol39389540833668106141163197235251
2012;42059540833468100130142
26(11):4362954083356887119146161173
1424–1430.4550954083346598130167198229262296309
63.39381053085367287
Zhu403810540833876113
QY,41641054083478189
Ma426710540835487
L,436710540833145
Luo442510540833168107
XQ,45451054083388497
Huang465610540834481114152191
HY.48601054083448089
Toxic49621054083336797112144
epidermal51201054083347388127162183242274289
necro‑542310540833772105126163187
lysis:3938115408315477489115128
performance408111540834480101122160182240273311343377
of447411540834261
SCORTEN455111540833878124160194229273
and484011540833775114
the497011540832665100
score-based508511540833264101123157180220253280315355
com‑545511540833774132155
parison39381254083397293108135173211
of416512540834161
the42411254083266499
efficacy4356125408338577592125157190223
of459412540834262
corticosteroid46711254083367394119134166203230253287308345361399
therapy50861254083266499120153193224
and532512540833775114
intra‑54541254083195779100133156
venous393813540833266104142180206
immunoglobulin415913540831270127165203241280295333373411426441478
combined465013540833168126165181218253293
therapy49581354083195792113146185216
in518913540831250
China.52521354083407792130162175
J5443135408321
Burn54771354083357394132
Care39381454083407394128
Res40811454083367197
2012;419414540833468100130142
33(6):43511454083356886119137149
e295–e308.451514540833469103137173210244279314327
64.39381553085367591
Jagadeesan404515540832860100133173208245272306345
S,440615540833549
Sobhanakumari447115540833574115154187226258289328387420442458
K,494515540833853
Sadanandan501415540833670109142181214253292325364
SM,539415540833691105
Ra‑55151554083387295
vidran39381654083324888109143182
S,413616540833548
Divakaran42021654083466295129160194216249288
MV,450816540835591101
Skaria462516540833565100121138170
L,481116540833448
Kurien48751654083377597113149188
G.508116540834358
Low515516540833472124
dose529716540833877104140
intra‑54531654083175577100133157
venous393817540833267105144183210
immunoglobulins416417540831877135174212251292308346387426442457496523
and470317540833574114
steroids48331754083295388110148164203230
in507917540831857
toxic51521754083256394110143
epidermal53111754083377793133168190249283299
necrolysis:393818540833873107129167183216244259286299
a4253185408338
prospective430718540834467105132172208242266282316351
comparative467418540833774134173207229263285301335370
open-labelled506018540834383119158182199232272308324340376416
stu‑54921854083325695118
dy393819540833972
of402719540834465
36410919540834077
cases.420219540833873101138166181
Indian439919540832261102119152192
J4608195408330
Dermatol466119540834684106167201224263280
Venereol495819540834277116153176212252269
Leprol524419540833874115138177194
2013;545519540834177110142154
79(4):39382054083346888122140152
506–511.410720540833469106144179210239249
65.39382153085367286
Lee404021540833166101
HY,41562154083448088
Lim425921540833247105
YL,43792154083356881
Thirumoorthy44752154083337287108147204243282303328366397
T,488721540833241
Pang494321540833567105144
SM.510221540833387101
The521821540833372107
role53402154083215874109
of546421540833756
in‑55362154083145274
travenous39382254083224376108142180218256283
immunoglobulin423622540831774132170208246286301339379417432447485
in473622540831755
toxic48062254083246191106138
epidermal49602254083367590129164185244276291
necrolysis:526922540833772105126163179211238253279292
a5576225408334
retrospective3938235408321557798136162201237270294309342376
analysis432923540833371103119150177192218
of456423540833756
64463623540833471
patients47232354083397294109144182203231
managed497023540835790128160199234274
in525923540831553
a5328235408332
speciali‑537623540832766101134149181196211234
zed393824540832862102
centre.405524540833165103125146180192
Br426324540833556
J4335245408324
Dermatol437424540834681102161193215252268
2013;465724540833468100130141
169(6):48142454083346599118151169181
1304–1309.50112454083346498134172203232267302313
66.39382553085367389
Aihara40462554083415694126148181
M,424625540835467
Kano432925540833872110148
Y,449225540833947
Fujita45552554083367287102125158
H,473225540834457
Kambara480425540833872130169202223256
T,507525540833745
Matsukura513925540835587109137174204242263296
S,545125540833649
Ka‑55152554083387295
tayama39382654083225485118176208
I,416226540831528
Azukizawa420626540834172111141157186220270303
H,452526540834557
Miyachi459926540835470101134167205220
Y,483526540833543
Endo489526540833270109147
Y,505926540833543
Asada511826540834169102141174
H,530826540834457
Miyaga‑538126540835570102135174206229
wa393827540835183
F,403627540833339
Morita409027540835493114130152185
E,429027540833346
Kaneko435127540833569107142172209
S,457527540833346
Abe463627540834180116
R,476727540833549
Ochiai483127540834780118133165180
T,502627540833342
Sueki508327540833270104135151
H,524927540834457
Watanabe532127540835889111144182214253289
H,393828540834457
Nagao401328540834577116149187
K,421528540833853
Aoyama428628540834178110143200233
Y,453428540833846
Sayama45962854083356899132190222
K,483328540833853
Hashimoto490428540834477103141156214252274311
K,523028540833853
Shiohara52982854083357388126165197218251
T.556528540833544
Efficacy3938295408333506886118151183216
of416729540833757
additional423729540833170109124147162200238271286
i.v.4538295408312255565
immunoglobulin461929540831269127165203241280296334373411426441479
to511329540832057
steroid51832954083264982104141156195
therapy53932954083205893114147186217
in393830540831553
Stevens-Johnson40053054083325387119153191218239260298337375401440478
syndrome44983054083255896135157194252287
and479930540833270109
toxic49233054083215888103135
epidermal50723054083347489128163184243275290
necroly‑537630540833873105127164180212234
sis.3938315408326416781
J4034315408324
Dermatol407331540834681102161193215252268
2015;435631540833468100130141
42(8):45123154083346784118136148
768–777.467531540833466102139170205239246
67.39383253085367079
Lalosevic40303254083316480118144179211226258
J,430332540832234
Nikolic43503254083445989126142157189
M,455132540835568
Gajic-Veljic46323254083437691106138156191224239254269301
M,494632540835467
Skiljevic5026325408333627894109143175191222
D,526132540834556
Medenica533032540835489128163201216247280
L.393833540833145
Stevens-Johnson39983354083335488120154192219240261299338376402440479
syndrome44923354083265997137158195253288
and479533540833270109
toxic49203354083215888104136
epidermal50713354083347389128163184242275290
necroly‑537633540833873106127164180212234
sis:3938345408326416780
a4033345408334
20-year40823454083377195127161193214
single-center43113454083294381120136171194227261299321354376
experience.470234540833668107143164180214252285318330
Int50483454083175576
J5140345408326
Dermatol518434540834580102160193214251267
2015;546634540833771103133144
54(8):39383554083346989122140152
978–984.410635540833467100137172207243256
68.39383653085367389
Yang404236540833565103142
L,419736540833246
Shou425636540833371109147
YH,44173654083358093
Li452436540833147
F,458536540833238
Zhu463736540833775113
XH,47643654083388295
Yang487336540833564102141
YS,50283654083356881
Xu512336540833874
JH.52123654083236781
Retrospec‑53073654083357092114151178217252285304
tive39383754083223770104
study40583754083315493132164
of423837540834261
213431537540833971101
cases44323754083366996131158
of460637540834261
Stevens-Johnson46833754083385993125160198225246267306344383409447486
syndrome518537540833164103142163201259295
and549537540833775115
toxic39383854083225990105138
epidermal40913854083407995134169191250283298
necrolysis440538540834378111133170186218246261287
from47083854083234683142
China.48663854083458399137170183
Burns506538540834079100139166
2019;524638540834074106137150
S03054179(19)30459-0.54113854083387310714217639383954083346494127146178208226259294330363395419456468
69.39384053085367386
Krajewski40404054083416497113148200227258274
A,433040540834661
Mazurek441240540835588118156178212243
MJ,46764054083558193
Mlynska-Krajewska479040540835571103143170200234256294316350365401452480510544
E,535040540833851
Piorun54174054083415594116155193
K,393841540833551
Knakiewicz400441540834182115146163198250266299331
M,435641540835569
Markowska444641540835689111142181233260291325
M.479341540835569
Toxic487841540833974105121154
epidermal50474154083408097136172194254287303
necroly‑536541540834480113135173190222245
sis39384254083264167
therapy40204254083256398119152191223
with42614254083506688126
TPE440342540833572104
and452242540833573112
IVIG-1046494254083185571115139169201
years486542540833468100121148
of503142540833857
experience510342540833768108144165180215253285319
of544042540833757
the55124254083246398
Burns39384354083357394132158
Treatment41084354083335084115137194229267288
Center.440943540833973110132165186196
J4620435408322
Burn46544354083367394132
Care47994354083407293127
Res49384354083367097
2019;504743540833468100129142
40(5):52024354083346988122140151
652–657.536643540833468100134171205238244
70.39384453085367186
Zimmermann404144540833853111169204225283316354392
S,444944540833245
Sekula45104454083326798136151183
P,471044540833539
Venhoff476544540833669107145183203222
M,500344540835468
Motschall508744540835493115142175213245260275
E,537844540833346
Knaus544044540833574107144170
J,393845540832436
Schumacher399045540833770108146204236269307342363
M,437445540835568
Mockenhaupt446345540835493126156190228267299337376398
M.488245540835569
Systemic49664554083386895118152210225258
immunomo‑523945540832078136174212250309347371
dulating39384654083387691123145160198237
therapies41904654083205893114147187202237264
for44694654083165476
Stevens-Johnson45584654083325387119154192218239260299337375402440478
syndrome50524654083245695134155192251286
and535146540833270109
toxic54754654083205787103135
epidermal39384754083347389128162184242274290
necrolysis:424347540834277110131168184216243258284296
a4555475408336
systematic46064754083306390113147205237259274306
review49274754083255991107142193
and513547540833674113
meta-analy‑526847540835792115147170202240272288320342
sis.3938485408326416781
JAMA403448540832464120162
Dermatol421148540834581102160193214251267
2017;449448540833468100129139
153(6):46484854083346497115149167179
514–522.48424854083346596133167200235248
71.39384953085367284
Borilova403949540834180102118133172205238
Linhartova42934954083375392130163185210248280314
P,462349540834045
Gachova468949540834478111149188221254
D,496449540834657
Lipovy50374954083375393132165200
B.525349540834154
Responsi‑532349540834177104144183222249264287
veness393850540833266104139166192
to414650540831956
i.v.4217505408313265666
immunoglobulin429850540831270128165203242281297335374412428443481
therapy47945054083195792114147186217
in502650540831351
patients50905054083387193108143181203230
with53335054083516689127
toxic54755054083205787103135
epidermal39385154083347490130166187247280296
necrolysis:424951540834479113134172189221249264291304
A4568515408347
novel463151540834382115150166
pharmaco-immunogenetic481351540834483116138197230263301325341400459497536575615651690725748764797
concept.393852540833168107139172212234247
J4200525408325
Dermatol424052540834581102160193214251267
2020.452352540833468101135147
doi:46865254083387691103
10.1111/1346-8138.15583.48055254083346578109136164192213247276312348371407439469504517548578610644678691